Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -12.04%490.3K | 343.60%1.23M | 257.17%955.26K | 798.86%2.1M | 587.07%976.19K | 1,532.01%557.45K | 860.33%277.55K | 833.63%267.45K | 97.30%233.78K | 142.08K |
| Selling and administrative expenses | -16.77%392.92K | 585.24%1.13M | 451.71%858.74K | 706.53%1.55M | 627.33%777.35K | 1,556.35%472.06K | 476.27%164.24K | 446.14%155.65K | 68.75%192.38K | --106.88K |
| -Selling and marketing expense | 798.19%134.73K | --679.52K | 2,184.43%356.99K | --57.94K | --27.32K | --15K | --0 | --15.63K | --0 | --0 |
| -General and administrative expense | -43.51%258.19K | 171.50%445.89K | 258.33%501.75K | 676.41%1.49M | 601.77%750.04K | 1,503.72%457.06K | 476.27%164.24K | 391.31%140.02K | 68.75%192.38K | --106.88K |
| Other operating expenses | 14.05%97.39K | -6.64%105.78K | -13.66%96.52K | 1,227.82%549.8K | 464.84%198.84K | 1,409.40%85.39K | 28,156.86%113.31K | 76,473.97%111.8K | 821.77%41.41K | --35.2K |
| Operating profit | 12.04%-490.3K | -343.60%-1.23M | -257.17%-955.26K | -798.86%-2.1M | -587.07%-976.19K | -1,532.01%-557.45K | -860.33%-277.55K | -833.63%-267.45K | -97.30%-233.78K | -142.08K |
| Net non-operating interest income (expenses) | -67.99K | -18.28K | 0 | 0 | ||||||
| Non-operating interest expense | --67.99K | --18.28K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Other net income (expenses) | -735.24K | -66.49K | -668.75K | |||||||
| Special income (charges) | --0 | ---- | ---- | ---735.24K | ---66.49K | ---668.75K | ---- | ---- | --0 | --0 |
| -Less:Impairment of capital assets | --0 | ---- | ---- | --680.81K | --12.06K | --668.75K | ---- | ---- | --0 | --0 |
| -Less:Write off | ---- | ---- | ---- | --54.42K | ---- | ---- | ---- | ---- | --0 | ---- |
| Income before tax | 54.47%-558.29K | -350.18%-1.25M | -257.17%-955.26K | -1,113.35%-2.84M | -633.87%-1.04M | -3,489.88%-1.23M | -860.33%-277.55K | -833.63%-267.45K | -97.30%-233.78K | -142.08K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 54.47%-558.29K | -350.18%-1.25M | -257.17%-955.26K | -1,113.35%-2.84M | -633.87%-1.04M | -3,489.88%-1.23M | -860.33%-277.55K | -833.63%-267.45K | -97.30%-233.78K | -142.08K |
| Net income continuous operations | 54.47%-558.29K | -350.18%-1.25M | -257.17%-955.26K | -1,113.35%-2.84M | -633.87%-1.04M | -3,489.88%-1.23M | -860.33%-277.55K | -833.63%-267.45K | -97.30%-233.78K | ---142.08K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 54.47%-558.29K | -343.60%-1.23M | -257.17%-955.26K | -1,113.35%-2.84M | -633.87%-1.04M | -3,489.88%-1.23M | -860.33%-277.55K | -833.63%-267.45K | -97.30%-233.78K | -142.08K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 54.47%-558.29K | -343.60%-1.23M | -257.17%-955.26K | -1,113.35%-2.84M | -633.87%-1.04M | -3,489.88%-1.23M | -860.33%-277.55K | -833.63%-267.45K | -97.30%-233.78K | -142.08K |
| Diluted earnings per share | 76.53%-0.01 | -314.72%-0.04 | -222.79%-0.03 | -1,130.92%-0.1 | -632.55%-0.0362 | -3,489.72%-0.0426 | -860.66%-0.0096 | -834.07%-0.0093 | -97.28%-0.0081 | -0.0049 |
| Basic earnings per share | 76.53%-0.01 | -314.72%-0.04 | -222.79%-0.03 | -1,130.92%-0.1 | -632.55%-0.0362 | -3,489.72%-0.0426 | -860.66%-0.0096 | -834.07%-0.0093 | -97.28%-0.0081 | -0.0049 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.